Immunoglobulin isotype-specific characterization of anti-human leukocyte antigen antibodies eluted from explanted renal allografts.

[1]  F. Heinemann,et al.  Detection of anti-MICA antibodies in patients awaiting kidney transplantation, during the post-transplant course, and in eluates from rejected kidney allografts by Luminex flow cytometry. , 2006, Human immunology.

[2]  I. Doxiadis,et al.  Exclusive Characteristics of Graft Survival and Risk Factors in Recipients with Immunoglobulin A Nephropathy: A Retrospective Analysis of Registry Data , 2005, Transplantation.

[3]  P. Terasaki,et al.  Serial Ten‐Year Follow‐Up of HLA and MICA Antibody Production Prior to Kidney Graft Failure , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[4]  P. D'Athis,et al.  Detection of anti-HLA antibodies with flow cytometry in needle core biopsies of renal transplants recipients with chronic allograft nephropathy. , 2005, Transplantation.

[5]  G. Opelz.  Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies , 2005, The Lancet.

[6]  I. Doxiadis,et al.  Detection and specification of noncomplement binding anti-HLA alloantibodies. , 2004, Human immunology.

[7]  E. Justrabo,et al.  Detection of donor-specific anti-HLA antibodies with flow cytometry in eluates and sera from renal transplant recipients with chronic allograft nephropathy1 , 2003, Transplantation.

[8]  P. Dyer,et al.  Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome1 , 2003, Transplantation.

[9]  P. Terasaki,et al.  Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities , 2003, Transplantation.

[10]  G. Vidarsson,et al.  Chimeric IgA antibodies against HLA class II effectively trigger lymphoma cell killing. , 2002, Blood.

[11]  C. Ponticelli,et al.  Kidney transplantation in patients with IgA mesangial glomerulonephritis. , 2001, Kidney international.

[12]  A. Zachary,et al.  Characterization of HLA class I specific antibodies by ELISA using solubilized antigen targets: II. Clinical relevance. , 2001, Human immunology.

[13]  G. Opelz,et al.  Graft-protective role of high pretransplantation IgA-anti-Fab autoantibodies: confirmatory evidence obtained in more than 4000 kidney transplants. The Collaborative Transplant Study. , 2000, Transplantation.

[14]  J. Kalil,et al.  Antibodies eluted from acutely rejected renal allografts bind to and activate human endothelial cells. , 1998, Human immunology.

[15]  T. Profaizer,et al.  Repeat donor HLA-DR mismatches in renal transplantation: is the increased failure rate caused by noncytotoxic HLA-DR alloantibodies? , 1999, Transplantation.

[16]  G. Opelz,et al.  The humoral immune response towards HLA class II determinants in renal transplantation. , 1996, Kidney international.

[17]  J. Banchereau,et al.  Interleukin-10 induces immunoglobulin G isotype switch recombination in human CD40-activated naive B lymphocytes , 1996, The Journal of experimental medicine.

[18]  P. Terasaki,et al.  Repeating HLA antigen mismatches in renal retransplants--a second class mistake? , 1994, Transplantation.

[19]  P. Terasaki,et al.  THE ROLE OF IgA ANTI‐HLA CLASS I ANTIBODIES IN KIDNEY TRANSPLANT SURVIVAL , 1993, Transplantation.

[20]  D. Gjertson,et al.  IN VITRO STUDIES TO EXPLAIN HIGH RENAL ALLOGRAFT SURVIVAL IN IGA NEPHROPATHY PATIENTS , 1993, Transplantation.

[21]  S. Ohlman,et al.  THE OCCURRENCE OF CYTOTOXIC AND NON‐COMPLEMENT‐FIXING ANTIBODIES IN THE CROSSMATCH SERUM OF PATIENTS WITH EARLY ACUTE REJECTION EPISODES , 1992, Transplantation.

[22]  P. Halloran,et al.  THE SIGNIFICANCE OF THE ANTI–CLASS I RESPONSE , 1992, Transplantation.

[23]  R. Gokal,et al.  Posttransplant antidonor lymphocytotoxic antibody production in relation to graft outcome. , 1987, Transplantation.

[24]  G. Busch,et al.  Immunologic monitoring of transplant rejection: correlation of in vitro assays with morphologic changes on transplant biopsy. , 1978, Nephron.

[25]  L. Sandu.  Letter: Corticosteroids in Landry-Guillain-Barré-Strohl syndrome. , 1974, Lancet.

[26]  T. Starzl,et al.  Human renal transplants. 3. Immunopathologic studies. , 1970, Laboratory investigation; a journal of technical methods and pathology.

[27]  P. Terasaki,et al.  Significance of the positive crossmatch test in kidney transplantation. , 1969, The New England journal of medicine.

[28]  T. Starzl,et al.  Human renal transplants , 1967 .

[29]  O. Fjeldborg,et al.  Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. , 1966, Lancet.

[30]  P. Terasaki,et al.  Microdroplet Assay of Human Serum Cytotoxins , 1964, Nature.